![](/img/cover-not-exists.png)
Data of pre-clinical and early clinical trials of acriflavine and hydroxy-methyl-ellipticine reviewed, enriched by the experience of their use for 18 months to 6 years in combinations with other HIV1 virostatics
G Mathé, K Triana, P Pontiggia, D Blanquet, M Hallard, C MoretteVolume:
52
Year:
1998
Language:
english
DOI:
10.1016/s0753-3322(99)80007-9
File:
PDF, 445 KB
english, 1998